ASMBAssembly Biosciences, Inc.

$22.80-4.4% 1Y

Is the price fair?

What ASMB's price assumes

Assembly Biosciences, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 7.73× revenue.

7.73

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
2.77

Price / book · as of 2026-Q1

EV / sales
7.33

EV / sales

Details›
Price / bookas of 2026-Q1
2.77
EV / salesas of 2026-Q1
7.33
Market capitalisation
$452M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.